S&P 500   3,934.38 (-0.73%)
DOW   33,476.46 (-0.90%)
QQQ   282.04 (-0.64%)
AAPL   142.16 (-0.34%)
MSFT   245.42 (-0.80%)
META   115.90 (+0.49%)
GOOGL   92.83 (-0.94%)
AMZN   89.09 (-1.39%)
TSLA   179.05 (+3.23%)
NVDA   170.01 (-0.98%)
NIO   12.63 (-5.82%)
BABA   91.34 (-3.01%)
AMD   68.59 (-2.67%)
T   19.09 (-0.16%)
MU   54.87 (-0.60%)
CGC   2.87 (-7.12%)
F   13.18 (+0.46%)
GE   81.45 (-2.61%)
DIS   93.38 (+0.90%)
AMC   5.94 (-2.14%)
PYPL   73.57 (-0.88%)
PFE   51.72 (-0.12%)
NFLX   320.01 (+3.14%)
S&P 500   3,934.38 (-0.73%)
DOW   33,476.46 (-0.90%)
QQQ   282.04 (-0.64%)
AAPL   142.16 (-0.34%)
MSFT   245.42 (-0.80%)
META   115.90 (+0.49%)
GOOGL   92.83 (-0.94%)
AMZN   89.09 (-1.39%)
TSLA   179.05 (+3.23%)
NVDA   170.01 (-0.98%)
NIO   12.63 (-5.82%)
BABA   91.34 (-3.01%)
AMD   68.59 (-2.67%)
T   19.09 (-0.16%)
MU   54.87 (-0.60%)
CGC   2.87 (-7.12%)
F   13.18 (+0.46%)
GE   81.45 (-2.61%)
DIS   93.38 (+0.90%)
AMC   5.94 (-2.14%)
PYPL   73.57 (-0.88%)
PFE   51.72 (-0.12%)
NFLX   320.01 (+3.14%)
S&P 500   3,934.38 (-0.73%)
DOW   33,476.46 (-0.90%)
QQQ   282.04 (-0.64%)
AAPL   142.16 (-0.34%)
MSFT   245.42 (-0.80%)
META   115.90 (+0.49%)
GOOGL   92.83 (-0.94%)
AMZN   89.09 (-1.39%)
TSLA   179.05 (+3.23%)
NVDA   170.01 (-0.98%)
NIO   12.63 (-5.82%)
BABA   91.34 (-3.01%)
AMD   68.59 (-2.67%)
T   19.09 (-0.16%)
MU   54.87 (-0.60%)
CGC   2.87 (-7.12%)
F   13.18 (+0.46%)
GE   81.45 (-2.61%)
DIS   93.38 (+0.90%)
AMC   5.94 (-2.14%)
PYPL   73.57 (-0.88%)
PFE   51.72 (-0.12%)
NFLX   320.01 (+3.14%)
S&P 500   3,934.38 (-0.73%)
DOW   33,476.46 (-0.90%)
QQQ   282.04 (-0.64%)
AAPL   142.16 (-0.34%)
MSFT   245.42 (-0.80%)
META   115.90 (+0.49%)
GOOGL   92.83 (-0.94%)
AMZN   89.09 (-1.39%)
TSLA   179.05 (+3.23%)
NVDA   170.01 (-0.98%)
NIO   12.63 (-5.82%)
BABA   91.34 (-3.01%)
AMD   68.59 (-2.67%)
T   19.09 (-0.16%)
MU   54.87 (-0.60%)
CGC   2.87 (-7.12%)
F   13.18 (+0.46%)
GE   81.45 (-2.61%)
DIS   93.38 (+0.90%)
AMC   5.94 (-2.14%)
PYPL   73.57 (-0.88%)
PFE   51.72 (-0.12%)
NFLX   320.01 (+3.14%)
NYSE:SYK

Stryker - SYK Stock Forecast, Price & News

$244.63
-3.21 (-1.30%)
(As of 12/9/2022 12:00 AM ET)
Add
Compare
Today's Range
$244.56
▼
$249.20
50-Day Range
$205.51
▼
$247.84
52-Week Range
$188.84
▼
$280.43
Volume
1.25 million shs
Average Volume
1.48 million shs
Market Capitalization
$92.58 billion
P/E Ratio
38.05
Dividend Yield
1.12%
Price Target
$245.56

Stryker MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.67 Rating Score
Upside/​Downside
0.4% Upside
$245.56 Price Target
Short Interest
Healthy
1.12% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-0.95
Upright™ Environmental Score
News Sentiment
0.16mentions of Stryker in the last 14 days
Based on 12 Articles This Week
Insider Trading
Selling Shares
$16.74 M Sold Last Quarter
Proj. Earnings Growth
7.20%
From $9.17 to $9.83 Per Share

Overall MarketRank™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

3.07 out of 5 stars

Medical Sector

9th out of 1,022 stocks

Surgical & Medical Instruments Industry

2nd out of 101 stocks

See Top Rated MarketRank™ Stocks Here
SYK stock logo

About Stryker (NYSE:SYK) Stock

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.

Receive SYK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Stryker and its competitors with MarketBeat's FREE daily newsletter.

SYK Stock News Headlines

November 13, 2022 | marketbeat.com
S&P 500 Component DexCom Set For Further Price, Earnings Growth (SYK)
Glucose monitor maker DexCom surged 19% after its Q3 report, and shares are holding those gains. Wall Street sees more growth ahead in 2023.
December 9, 2022 | americanbankingnews.com
Srikant M. Datar Sells 500 Shares of Stryker Co. (NYSE:SYK) Stock
December 9, 2022 | americanbankingnews.com
Srikant M. Datar Sells 1,000 Shares of Stryker Co. (NYSE:SYK) Stock
December 8, 2022 | finance.yahoo.com
Investors Interested In Stryker Corporation's (NYSE:SYK) Earnings
December 8, 2022 | americanbankingnews.com
Stryker Co. (NYSE:SYK) CEO Kevin Lobo Sells 67,232 Shares
December 4, 2022 | finance.yahoo.com
Selling US$874k worth of Stryker Corporation (NYSE:SYK) stock at high prices would have gotten insiders a handsome reward
December 4, 2022 | americanbankingnews.com
Barclays Raises Stryker (NYSE:SYK) Price Target to $257.00
November 30, 2022 | finance.yahoo.com
Investors in Stryker (NYSE:SYK) have made a notable return of 58% over the past five years
November 26, 2022 | finance.yahoo.com
What Is Stryker Corporation's (NYSE:SYK) Share Price Doing?
November 22, 2022 | finance.yahoo.com
When Should You Buy Stryker Corporation (NYSE:SYK)?
November 18, 2022 | finance.yahoo.com
Earnings Tell The Story For Stryker Corporation (NYSE:SYK)
November 14, 2022 | finance.yahoo.com
Stryker opens the OR of the Future for customers to experience tomorrow's OR today
November 9, 2022 | finance.yahoo.com
As Stryker Corporation's (NYSE:SYK)) market cap dropped by US$3.9b, insiders who sold US$1.1m worth of stock were able to offset their losses
November 5, 2022 | finance.yahoo.com
Institutional investors may adopt severe steps after Stryker Corporation's (NYSE:SYK) latest 8.0% drop adds to a year losses
November 5, 2022 | finance.yahoo.com
2 Under-the-Radar Medtech Stocks to Buy Now
November 4, 2022 | finance.yahoo.com
Stryker to participate in the 5th Annual Evercore ISI HealthCONx Conference
November 1, 2022 | finance.yahoo.com
Stryker reports third quarter 2022 operating results
November 1, 2022 | finance.yahoo.com
Stryker (SYK) Misses Q3 Earnings Estimates
November 1, 2022 | finance.yahoo.com
Estimating The Intrinsic Value Of Stryker Corporation (NYSE:SYK)
November 1, 2022 | finance.yahoo.com
Stryker Reports Q3 Earnings Miss Due To High Component Prices, Cuts Full Year Profit Guidance
October 28, 2022 | finance.yahoo.com
Stryker's (NYSE:SYK) Returns On Capital Not Reflecting Well On The Business
October 27, 2022 | finance.yahoo.com
Here’s Why Diamond Hill Capital Added Stryker Corporation (SYK) to its Portfolio
October 24, 2022 | finance.yahoo.com
Positive week for Stryker Corporation (NYSE:SYK) institutional investors who lost 20% over the past year
October 16, 2022 | finance.yahoo.com
Is There Now An Opportunity In Stryker Corporation (NYSE:SYK)?
October 13, 2022 | nasdaq.com
December 2nd Options Now Available For Stryker Corp (SYK) - Nasdaq
See More Headlines
Receive SYK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Stryker and its competitors with MarketBeat's FREE daily newsletter.

SYK Company Calendar

Ex-Dividend for 10/31 Dividend
9/29/2022
Last Earnings
10/31/2022
Dividend Payable
10/31/2022
Today
12/09/2022
Ex-Dividend for 1/31 Dividend
12/29/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
1/26/2023
Dividend Payable
1/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Sector
Medical
Current Symbol
NYSE:SYK
CUSIP
86366710
CIK
310764
Web
www.strykercorp.com
Phone
(269) 385-2600
Fax
269-385-1062
Employees
46,000
Year Founded
1941

Price Target and Rating

Average Stock Price Forecast
$245.56
High Stock Price Forecast
$295.00
Low Stock Price Forecast
$205.00
Forecasted Upside/Downside
+0.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.67
Research Coverage
18 Analysts

Profitability

EPS (Most Recent Fiscal Year)
$6.43
Trailing P/E Ratio
38.05
Forward P/E Ratio
26.68
P/E Growth
2.99
Net Income
$1.99 billion
Net Margins
13.69%
Pretax Margin
14.93%
Return on Equity
22.27%
Return on Assets
9.68%

Debt

Debt-to-Equity Ratio
0.77
Current Ratio
2.04
Quick Ratio
1.19

Sales & Book Value

Annual Sales
$17.11 billion
Price / Sales
5.41
Cash Flow
$11.95 per share
Price / Cash Flow
20.47
Book Value
$39.42 per share
Price / Book
6.21

Miscellaneous

Outstanding Shares
378,430,000
Free Float
353,075,000
Market Cap
$92.58 billion
Optionable
Optionable
Beta
0.98

Social Links


Key Executives

  • Mr. Kevin A. LoboMr. Kevin A. Lobo (Age 57)
    Chairman, CEO & Pres
    Comp: $3.59M
  • Mr. Glenn S. BoehnleinMr. Glenn S. Boehnlein (Age 60)
    VP & CFO
    Comp: $1.46M
  • Mr. Timothy John ScannellMr. Timothy John Scannell (Age 57)
    Exec. Advisor
    Comp: $1.74M
  • Mr. Viju S. Menon (Age 54)
    Group Pres of Global Quality & Operations
    Comp: $1.08M
  • Mr. J. Andrew Pierce (Age 48)
    Group Pres of MedSurg & Neurotechnology
    Comp: $1.41M
  • Mr. Spencer S. Stiles (Age 45)
    Group Pres of Orthopaedics & Spine
    Comp: $1.33M
  • Mr. William E. Berry Jr.Mr. William E. Berry Jr. (Age 56)
    VP & Chief Accounting Officer
  • Mr. Robert C. Cohen
    CTO and VP of Global R&D - Joint Replacement
  • Mr. Alan Douville
    VP, Chief Information Officer & Chief Information Security Officer
  • Mr. Jason Beach
    VP of Investor Relations

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions













SYK Stock - Frequently Asked Questions

Should I buy or sell Stryker stock right now?

18 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Stryker in the last twelve months. There are currently 6 hold ratings and 12 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" SYK shares.
View SYK analyst ratings or view top-rated stocks.

What is Stryker's stock price forecast for 2023?

18 Wall Street research analysts have issued 12 month target prices for Stryker's shares. Their SYK share price forecasts range from $205.00 to $295.00. On average, they expect the company's share price to reach $245.56 in the next twelve months. This suggests that the stock has a possible downside of 0.5%.
View analysts price targets for SYK or view top-rated stocks among Wall Street analysts.

How have SYK shares performed in 2022?

Stryker's stock was trading at $267.42 on January 1st, 2022. Since then, SYK shares have decreased by 7.7% and is now trading at $246.85.
View the best growth stocks for 2022 here.

Are investors shorting Stryker?

Stryker saw a decrease in short interest during the month of November. As of November 15th, there was short interest totaling 3,920,000 shares, a decrease of 22.2% from the October 31st total of 5,040,000 shares. Based on an average daily trading volume, of 1,480,000 shares, the short-interest ratio is currently 2.6 days. Currently, 1.1% of the company's shares are short sold.
View Stryker's Short Interest.

When is Stryker's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, January 26th 2023.
View our SYK earnings forecast.

How were Stryker's earnings last quarter?

Stryker Co. (NYSE:SYK) announced its earnings results on Monday, October, 31st. The medical technology company reported $2.12 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $2.24 by $0.12. The medical technology company had revenue of $4.48 billion for the quarter, compared to analysts' expectations of $4.46 billion. Stryker had a net margin of 13.69% and a trailing twelve-month return on equity of 22.27%. The business's quarterly revenue was up 7.7% compared to the same quarter last year. During the same period in the prior year, the business earned $2.20 EPS.

How often does Stryker pay dividends? What is the dividend yield for Stryker?

Stryker declared a quarterly dividend on Wednesday, December 7th. Shareholders of record on Friday, December 30th will be given a dividend of $0.75 per share on Tuesday, January 31st. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.22%. The ex-dividend date of this dividend is Thursday, December 29th. This is a boost from the stock's previous quarterly dividend of $0.70.
Read our dividend analysis for SYK.

Is Stryker a good dividend stock?

Stryker (NYSE:SYK) pays an annual dividend of $2.78 per share and currently has a dividend yield of 1.15%. The company has been increasing its dividend for 28 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 43.23%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, SYK will have a dividend payout ratio of 28.28% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for SYK.

What guidance has Stryker issued on next quarter's earnings?

Stryker updated its FY 2022 earnings guidance on Monday, November, 7th. The company provided earnings per share guidance of $9.15-$9.25 for the period, compared to the consensus EPS estimate of $9.36. The company issued revenue guidance of -.

What is Kevin A. Lobo's approval rating as Stryker's CEO?

1,492 employees have rated Stryker Chief Executive Officer Kevin A. Lobo on Glassdoor.com. Kevin A. Lobo has an approval rating of 97% among the company's employees. This puts Kevin A. Lobo in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Stryker own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Stryker investors own include Johnson & Johnson (JNJ), Walt Disney (DIS), Home Depot (HD), Medtronic (MDT), Visa (V), AbbVie (ABBV), Cisco Systems (CSCO), Intel (INTC), QUALCOMM (QCOM) and NVIDIA (NVDA).

What is Stryker's stock symbol?

Stryker trades on the New York Stock Exchange (NYSE) under the ticker symbol "SYK."

Who are Stryker's major shareholders?

Stryker's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (7.87%), BlackRock Inc. (6.25%), Price T Rowe Associates Inc. MD (5.32%), Greenleaf Trust (5.23%), State Street Corp (3.71%) and Bank of New York Mellon Corp (1.77%). Insiders that own company stock include Allan C Golston, Glenn S Boehnlein, Katherine Ann Owen, Kevin Lobo, M Kathryn Fink, Robert S Fletcher, Roch Doliveux, Ronda E Stryker, Srikant M Datar and Timothy J Scannell.
View institutional ownership trends.

How do I buy shares of Stryker?

Shares of SYK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Stryker's stock price today?

One share of SYK stock can currently be purchased for approximately $246.85.

How much money does Stryker make?

Stryker (NYSE:SYK) has a market capitalization of $93.42 billion and generates $17.11 billion in revenue each year. The medical technology company earns $1.99 billion in net income (profit) each year or $6.43 on an earnings per share basis.

How many employees does Stryker have?

The company employs 46,000 workers across the globe.

Does Stryker have any subsidiaries?
The following companies are subsidiares of Stryker: 2Hip Holdings SAS, ActiViews, Aimago SA, Alcott Indemnity Company, Arrinex Inc., Arrinex Inc., Ascent Healthcare Solutions, Berchtold, Berchtold + Fritz GmbH, Berchtold Consulting GmbH, Berchtold Corporation, Berchtold GmbH & Co. KG, Berchtold Holding Switzerland GmbH, BioMimetic Therapeutics LLC, BioMimetic Therapeutics USA Inc., CHG Hospital Beds, Cactus LLC, Cardan Robotics, Cartiva Inc., Changzhou Orthomed Medical Instrument Company Limited, Concentric Medical, EnMovi Ltd., Entellus Medical, Entellus Medical Inc., GYS Tech LLC, Gauss Surgical, Gauss Surgical Inc., Gauss Surgical Singapore Pte. Ltd., Gaymar Industries, Gongping (Shanghai) Medical Devices Trading Co. Ltd., Groupe Bertec, HeartSine Technologies LLC, HeartSine Technologies Limited, Howmedica International S. de R.L., Howmedica Osteonics Corp., Hygia Health Services, Hygia Healthcare Services Inc., HyperBranch, HyperBranch Medical Technologies Inc., HyperBranch Medical Technology, Image Guided Technologies, Imascap SAS, Imorphics Limited, Infinity MSD Corp., Infinity MSF Corp., Infomedix Communications, Instratek, InstruMedics L.L.C, Invuity, Invuity Inc., Ivy Sports Medicine, Ivy Sports Medicine LLC, Jiangsu Chuangyi Medical Instrument Company Limited, Jolife AB, K2M Group, K2M Group Holdings Inc., K2M Holdings Inc., K2M Inc., K2M UK Limited, Loon Intermediateco LLC, MAKO Surgical, MAKO Surgical Corp, Memometal Technologies, Mobius Imaging, Mobius Imaging LLC, Muka Metal, Muka Metal Ticaret ve Sanayi Anaonim Sirketi, NV Stryker SA, Nettrick Limited, Novadaq Corp, Novadaq Technologies, Novadaq Technologies ULC, OOO "Stryker", Orneo Özel Sağlık Hizmetleri Medikal Ticaret Anonim Şirketi, Ortho-Space Ltd., OrthoHelix Surgical Designs Inc., OrthoSensor, OrthoSensor Korea Ltd, OrthoSpace, OrthoSpace US Inc., Orthomed (Hong Kong) Medical Instrument Company Limited, Orthosensor Inc., Orthovita, Orthovita Inc., OtisMed, P.C. Sweden Holding AB, PTH West LLC, Patient Safety Technologies, Patton Surgical, Physio-Control, Physio-Control (Shanghai) Sales Co. Ltd., Physio-Control Brazil Vendas Ltda., Physio-Control Holdings Coöperatief U.A., Physio-Control Holdings Inc, Physio-Control Inc., Physio-Control Investments LLC, Physio-Control Lebanon Sales Offshore s.a.l., Physio-Control Manufacturing Inc., Physio-Control Operations Netherlands B.V., Physio-Control Sales Limited Liability Company, Pivot Medical, PlasmaSol, Porex Technologies, SCI Calyx SA, SSI Divestiture Inc., SYK Costa Rica Services Sociedad De Responsabilidad Limitada, SafeAir AG, SafeWire, Sage Products, Sage Products Coӧperatief U.A., Sage Products Holdings II LLC, Sage Products Holdings III LLC, Sage Products LLC, Scopis, Scopis GmbH, Sightline Technologies, Small Bone Innovations, SpineCore, Spirox Inc., Stanmore Implants Worldwide, Stanmore Implants Worldwide Limited, Stanmore Inc., Stryker (Barbados) Foreign Sales Corporation, Stryker (Beijing) Healthcare Products Co. Ltd., Stryker (Shanghai) Healthcare Products Co. Ltd., Stryker (Suzhou) Medical Technology Co Ltd, Stryker (Thailand) Limited, Stryker AB, Stryker Acquisitions B.V., Stryker Asia Holdings C.V., Stryker Australia LLC, Stryker Australia Pty. Ltd., Stryker Austria GmbH, Stryker B.V., Stryker Berchtold B.V., Stryker Beteiligungs GmbH, Stryker Canada Holding Company ULC, Stryker Canada Manufacturing ULC, Stryker Canada ULC, Stryker Canadian Management ULC, Stryker Capital B.V., Stryker China Limited, Stryker Colombia SAS, Stryker Communications Inc., Stryker Corporation (Chile) y Compania Limitada, Stryker Corporation (Malaysia) Sdn. Bhd., Stryker Customs Brokers LLC, Stryker Czech Republic s.r.o., Stryker Delaware Inc., Stryker EMEA Supply Chain Services B.V., Stryker Employment Company LLC, Stryker European Holdings Coöperatief U.A, Stryker European Holdings LLC, Stryker European Operations B.V., Stryker European Operations Holdings I B.V., Stryker European Operations Holdings II B.V., Stryker European Operations Holdings III B.V., Stryker European Operations Holdings LLC, Stryker European Operations Limited, Stryker Far East Inc., Stryker Foreign Acquisitions Inc., Stryker France SAS, Stryker Funding B.V., Stryker Global Technology Center Private Limited, Stryker GmbH, Stryker GmbH & Co. KG, Stryker Grundstücks GmbH & Co KG, Stryker Grundstücks Verwaltungs GmbH, Stryker Holdings B.V., Stryker IFSC Designated Activity Company, Stryker Iberia S.L. Unipersonal, Stryker India Private Limited, Stryker International Acquisitions B.V., Stryker International Holdings B.V., Stryker Ireland Limited, Stryker Italia S.r.l., Stryker Japan K.K., Stryker Korea Ltd., Stryker Lebanon (Offshore) S.A.L., Stryker Leibinger GmbH & Co. KG, Stryker Luxembourg Sarl, Stryker Malta Holdings Limited, Stryker Manufacturing Holdings B.V., Stryker Manufacturing S. de R.L. de C.V., Stryker Mauritius Holding Ltd., Stryker Medical London LP, Stryker Medtech K.K., Stryker Medtech Limited, Stryker Mexico Holdings B.V., Stryker Mexico SA de CV, Stryker NV Operations Limited, Stryker Nederland B.V., Stryker New Zealand Limited, Stryker Osteonics AG, Stryker Pacific Limited, Stryker Performance Solutions LLC, Stryker Poland Services sp. z o.o., Stryker Polska Sp.z.o.o., Stryker Portugal - Produtos Medicos Unipessoal Lda., Stryker Professional Latin America S. de R.L. de C.V., Stryker Puerto Rico Holdings B.V., Stryker Puerto Rico LLC, Stryker Puerto Rico Sales LLC, Stryker Renovation Services LLC, Stryker Romania SRL, Stryker Sales LLC, Stryker Servicios Administrativos S.de R.L. de C.V., Stryker Singapore Private Limited, Stryker South Africa (Proprietary) Limited, Stryker Spine SAS, Stryker Spine Sarl, Stryker Sustainability Solutions Inc., Stryker Tibbi Cihazlan Sanayi ve Ticaret Limited Sirketi, Stryker Tijuana Operations S. de R.L. de C.V., Stryker Trauma GmbH, Stryker Turkish Holdings B.V., Stryker UK Limited, Stryker Unite Ltd., Stryker Verwaltungs GmbH, Stryker Vietnam Company Limited, Stryker do Brasil Ltda, Surpass Medical, Synergetics, TMG France SAS, TMJ Solutions LLC, TSO3 Corporation, TSO3 Inc., Thermedx LLC, Tornier Inc., Tornier Orthopedics Ireland Limited, Tornier Pty Ltd., Tornier SAS, Tornier Scandinavia A/S, Tornier UK Limited, Tornier US Holdings Inc., Trauson, Trauson (China) Medical Instrument Company Limited, Trauson (Hong Kong) Company Limited, Trauson Holdings (B.V.I.) Company Limited, Trauson Holdings (Hong Kong) Company Limited, Trauson Holdings Company Limited, Trooper Holdings Inc., Vexim, Vocera, Vocera Communications, Wright DutchCo B.V., Wright Medical Australia Pty Limited, Wright Medical Brasil Ltda, Wright Medical Costa Rica S.A., Wright Medical Device (Shanghai) Co. Ltd., Wright Medical Group, Wright Medical Group Inc., Wright Medical Netherlands B.V., Wright Medical Singapore Pte Ltd, Wright Medical Technology Inc., Wright Medical UK Ltd, Wright PacRim Inc., ZipLine Medical Consulting (Shanghai) Co. Ltd., ZipLine Medical Hong Kong Limited, ZipLine Medical Inc., and eTrauma.com.
Read More
How can I contact Stryker?

Stryker's mailing address is 2825 AIRVIEW BLVD, KALAMAZOO MI, 49002. The official website for the company is www.strykercorp.com. The medical technology company can be reached via phone at (269) 385-2600, via email at katherine.owen@stryker.com, or via fax at 269-385-1062.

This page (NYSE:SYK) was last updated on 12/9/2022 by MarketBeat.com Staff